Medicines optimisation - Fylde Coast Clinical Commissioning Groups

Medicines play an important part in promoting wellbeing, preventing ill health and managing disease. More than 700million prescription items are dispensed in England each year with a cost approaching £8billion.

Medicines management can be defined in several ways:

The clinical, cost-effective, safe and secure handling of medicines.
A system of processes and behaviours that determines how medicines are used by the NHS and patients.
Enabling people to make the best possible use of medicines.

Our goal is to achieve the best health outcomes for patients where medicines are involved.

Many decisions relating to medicines management on the Fylde Coast are made on a Lancashire and South Cumbria-wide basis by the Lancashire and South Cumbria Medicines Management Group (LSCMMG).

Further information on medicine guidelines, prescribing guidance, position statements and supporting documents, shared care guidelines and high-cost medicines can be found on the LSCMMG website.

CLICK HERE FOR LSCMMG

Click each header to expand its content

Fylde Coast medicines RAG list

Fylde Coast CCGs RAG List V1 June 2022 (xlsx | 81 KB)

Anti-infective

Name	Size	Hits
Antimicrobial Formulary April 2021	3.5 MB	339
Antimicrobial Summary Additional information April 2021	25 KB	132

Blood and nutrition

Gluten-free

Name	Size	Hits
Gluten Free Foodstuffs	0.2 MB	386
Gluten-Free-Food-Products	0.3 MB	342

Sip feed

Name	Size	Hits
Clinical Need Thickeners Position Statement	0.3 MB	751
Oral Nutritional Supplements (ONS) in care and nursing homes	0.2 MB	527
Position Statement Sip Feeds	0.4 MB	395
SIP Feeds	0.1 MB	464

DVT/VTE/PE

Name	Size	Hits
Dalteparin SCG 2018	0.2 MB	528
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use	0.1 MB	319

Vitamin D

Name	Size	Hits
Flowchart-for-Vitamin-D-Deficiency-in-Primary-Care	0.3 MB	1058

Vitamins and minerals

Name	Size	Hits
Policy Unlicensed Herbal Vits Mins Supplements 2013	77 KB	280

Cardiovascular system

Name	Size	Hits

Ear, nose and oropharynx

Name	Size	Hits

Endocrine system

Blood glucose meters and strips (under review)

Name	Size	Hits
Blood glucose meters and test strips Type 2 Diabetes (Blackpool)	0.5 MB	1964
Blood Glucose meters and test strips Type 2 Diabetes (Fylde and Wyre)	1.2 MB	128

Diabetes

Name	Size	Hits
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus	0.3 MB	383

Thyroid

Name	Size	Hits
Liothyronine position statement	0.2 MB	354

Eye

Name	Size	Hits

Gastro-intestinal system

Stoma care product

Name	Size	Hits

Genito-urinary system

Name	Size	Hits
Prophylactic supply of catheters post pelvic organ prolapse	0.2 MB	345

Gender dysphoria

Name	Size	Hits
20160422-SSC1620_Primary-Care-Responsibilities-in-Prescribing-and-Monitoring-Hormone-Therapy	0.3 MB	118
Good-practice-guidelines-for-Gender-Dysphoria	0.6 MB	92
Interim Gender Dysphoria Protocol and Service Guidelines 2013-14	0.6 MB	90

Musculoskeletal system

Arthritis

Name	Size	Hits
Botulinum Toxin A for Spasticity and Contracture of the joint	0.3 MB	336
Second Line Anti-TNF For PsA	0.2 MB	316

DMARDs

Name	Size	Hits
Denosumab for GIO	0.2 MB	346

DMARDs shared care

Name	Size	Hits
azathioprinemercaptopurine-shared-care-guideline-version-21	0.2 MB	78
Ciclosporin-SCG-Version	0.2 MB	100
Leflunomide-SCG-Version	0.2 MB	93
Methotrexate-SCG-Version	0.2 MB	115
Penicillamine-SCG-Version	0.2 MB	82
Sodium-Aurothiomalate-SCG-Version	0.2 MB	86
Sulfasalazine-SCG-Version	0.2 MB	92

Other MSK

Name	Size	Hits

Nervous system (pain management and psychotics)

Antipsychotic

Name	Size	Hits
Guidance for Prescribing Second Generation Long Acting Antipsychotic Injections	0.6 MB	326
Guidance to support the implementation of the valproate PREVENT programme	0.5 MB	533

Dementia

Name	Size	Hits
Management-of-Behavioural-and-Psychological-Symptoms-of-Dementia-Primary-Care-Summary-Document	0.2 MB	390

Pain

Name	Size	Hits
Cannabis-based-medication-desk-guide-Nov-2018 December-Edit	0.6 MB	348
Clinical Need Soluble Analgesics	0.5 MB	1731
Position Statement OPIOID PRESCRIBING max dose Version 1.2 Nov 21	0.1 MB	48

Chronic pain

Name	Size	Hits

Non-chronic pain

Name	Size	Hits

Respiratory system

Name	Size	Hits

Asthma

Name	Size	Hits

COPD

Name	Size	Hits

Inhaler techniques

Name	Size	Hits
How-to-use-your-Accuhaler-inhaler-A4	37 KB	348
How-to-use-your-Aerolizer-inhaler-A4	36 KB	292
How-to-use-your-Autohaler-inhaler-A4	32 KB	302
How-to-use-your-Breezhaler-inhaler-A4	40 KB	342
How-to-use-your-Clickhaler-inhaler-A4	32 KB	333
How-to-use-your-Easi-breathe-inhaler-A4	33 KB	261
How-to-use-your-Easyhaler-inhaler-A4	37 KB	428
How-to-use-your-Ellipta-inhaler-A4	31 KB	476
How-to-use-your-Forspiro-inhaler-A4	48 KB	261
How-to-use-your-Genuair-inhaler-A4	41 KB	460
How-to-use-your-metered-dose-inhaler-A4	51 KB	287
How-to-use-your-metered-dose-inhaler-with-large-volume-spacer-device-A4- ..	37 KB	297
How-to-use-your-metered-dose-inhaler-with-small-volume-spacer-device-A4- ..	35 KB	296
How-to-use-your-NEXThaler-inhaler-A4	88 KB	282
How-to-use-your-Novolizer-inhaler-A4	42 KB	295
How-to-use-your-Respimat-inhaler-A4-leaflet	44 KB	288
How-to-use-your-Spiriva-HandiHaler-inhaler-A4	32 KB	255
How-to-use-your-Spiromax-inhaler-A4	44 KB	304
How-to-use-your-Turbohaler-inhaler-A4	34 KB	431

E-cigarettes

Name	Size	Hits
Health-Professionals-e-cigarettes-briefing-blackpool-council-final	0.2 MB	80

Skin

Name	Size	Hits
Emollients and Sunscreens	0.2 MB	932
Wound Care Formulary V4 April 2021	1.6 MB	2024

Miscellaneous

Name	Size	Hits
Free of Charge (FOC) Medicines schemes	0.3 MB	380
NWC-SCN01-Clinical-Practice-Summary-Palliative-Care-Final-version	0.6 MB	420

Prescribing process

Name	Size	Hits
28 Day Prescribing	0.3 MB	966
Changes to repeat prescribing in Blackpool – Frequently Asked Questions	0.4 MB	228
Clinical Need Low Priority Medicines - General	0.3 MB	691
Conditions for which over the counter items should not routinely be prescribed in primary care	0.9 MB	729
Electronic-Repeat-Dispensing-guideline	1.7 MB	2620
Generic Prescribing Guidelines	0.3 MB	603
Guidance-for-7-day-prescriptions-FWCCG-Apr2018	0.5 MB	811
Holiday Medication	0.2 MB	708
MDS Briefing Doc Oct 13	43 KB	328

Other policies

Name	Size	Hits

Rebate policies

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third-party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Fylde & Wyre Current Primary Care Rebate Schemes in place:

Clenil Modulite (Beclometasone) – commenced July 2019
Dabigatran (Pradaxa) – commenced November 2020
Degarelix (Firmagon) – commenced September 2016
Fostair NEXThaler – commenced May 2021
Fostair pMDI – commenced July 2021
Fencino (Fentanyl) – commenced April 2016
Longtec – commenced July 2019
Prostap (Leuprorelin) – commenced April 2020
Rivaroxaban (Xarelto) – commenced October 2019
Sereflo – commenced July 2019
Toujeo (Insulin Glargine) – commenced July 2021
Zacco (Clobazam) – commenced March 2021

Blackpool Current Primary Care Rebate Schemes in place:

Clenil Modulite (Beclometasone) – commenced July 2019
Dabigatran (Pradaxa) – commenced November 2020
Degarelix (Firmagon) – commenced September 2016
Fostair NEXThaler – commenced May 2021
Fostair pMDI – commenced July 2021
Fencino (Fentanyl) – commenced October 2018
Longtec – commenced July 2019
Prostap (Leuprorelin) – commenced April 2020
Rivaroxaban (Xarelto) – commenced July 2019
Sereflo – commenced July 2019
Toujeo (Insulin Glargine) – commenced July 2021
Zacco (Clobazam) – commenced March 2021

Care homes

Vitamin D and care homes guidance – GOV.UK (www.gov.uk)

Proxy access

LSC ICS Proxy ordering of medication in Care Homes – Lancashire and South Cumbria Medicines Management Group (lancsmmg.nhs.uk)

If you can’t find what you are looking for and think it was once listed in these pages, try the LSCMMG or our files archive